New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
06:54 EDTMYGN, LHMyriad remains in Horizon New Jersey network, says William Blair
William Blair believes there is confusion around Horizon BCBS of New Jersey's BRCA commentary, which it feels attributed to the recent pullback in shares of Myriad Genetics (MYGN). The firm said Horizon reiterated LabCorp's (LH) preferred network status and suggested that doctors should use LabCorp for BRCA testing. The insurer does not refer to a change in Myriadís network status as a participating provider in Horizonís network, the firm points out. William Blair says it has not seen evidence that Myriad is being excluded as a network provider. It maintains an Outperform rating on the stock.
News For MYGN;LH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
07:33 EDTLHLabCorp says Deborah Keller to succeed Joseph Herring as Covance CEO
LabCorp announced that Deborah Keller will succeed Joseph Herring as CEO of Covance Drug Development. Herring will retire on July 31 after more than a decade as CEO. Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance, and marketing over her tenure. Most recently she served as Executive Vice President, Covance and Group President, R&D Laboratories, where she led the combined central laboratory and early development laboratory organizations of more than 6,000 employees at 18 facilities across the globe.
07:17 EDTLHLabCorp raises FY15 adjusetd EPS view to $7.75-$8.00 from $7.55-$7.90
Subscribe for More Information
07:16 EDTLHLabCorp reports Q2 adjusted EPS $2.09, consensus $2.03
Subscribe for More Information
July 27, 2015
15:03 EDTLHNotable companies reporting before tomorrow's open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use